Loading Valuation Snapshot...
Stock DNA
Pharmaceuticals & Drugs
INR 13,907 Cr (Mid Cap)
140.00
33
0.00%
0.56
9.52%
13.33
Revenue and Profits (1 Year):
Net Sales:
440 Cr
(Quarterly Results - Dec 2024)
Net Profit:
54 Cr
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s Sensex 
Returns Beta
Beta has not been calculated since enough price history is not available
Quality key factors 
Factor
Value
Sales Growth (5y)
22.60%
EBIT Growth (5y)
138.04%
EBIT to Interest (avg)
1.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0
Tax Ratio
26.18%
Dividend Payout Ratio
0
Pledged Shares
2.67%
Institutional Holding
23.67%
ROCE (avg)
0
ROE (avg)
6.10%
Valuation key factors
Factor
Value
P/E Ratio
140
Industry P/E
33
Price to Book Value
13.33
EV to EBIT
77.48
EV to EBITDA
48.50
EV to Capital Employed
8.92
EV to Sales
9.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.51%
ROE (Latest)
9.52%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
Shareholding Snapshot : Jul 2024
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
2.6885
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Mytreyi Kanumuri Partner Of Marigold Partners (partnership Firm) (10.67%)
Highest Public shareholder
Tpg Asia Vii Sf Pte Ltd (24.78%)
Individual Investors Holdings
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ
Dec'24
Sep'24
Change(%)
Net Sales
428.60
381.97
12.21%
Operating Profit (PBDIT) excl Other Income
111.19
100.77
10.34%
Interest
21.66
19.45
11.36%
Exceptional Items
0.00
0.00
Standalone Net Profit
51.06
43.85
16.44%
Operating Profit Margin (Excl OI)
25.94%
26.38%
-0.44%
Values in Rs Cr.
Net Sales
QoQ Growth in quarter ended Dec 2024 is 12.21% vs 2.51% in Sep 2024
Standalone Net Profit
QoQ Growth in quarter ended Dec 2024 is 16.44% vs 9.13% in Sep 2024
Annual Results Snapshot (Standalone) - Mar'24
Mar'24
Mar'23
Change(%)
Net Sales
1,418.68
1,157.40
22.57%
Operating Profit (PBDIT) excl Other Income
286.60
163.13
75.69%
Interest
79.72
70.64
12.85%
Exceptional Items
0.00
0.00
Standalone Net Profit
95.23
24.24
292.86%
Operating Profit Margin (Excl OI)
20.20%
14.09%
6.11%
Values in Rs Cr.
Net Sales
Not Applicable: The company has declared_date for only one period
Standalone Net Profit
Not Applicable: The company has declared_date for only one period
About Sai Life Sciences Ltd 
Sai Life Sciences Ltd
Mid Cap
Pharmaceuticals & Drugs
Sai Life Sciences Limited was originally incorporated as `Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999. Subsequently, the Company name was changed from `Sai Dru Syn Laboratories Limited' to `Sai Life Sciences Limited' dated December 16, 2003.
Company Coordinates 
No Company Details Available